Vontobel Holding’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,200
Closed -$771K 1285
2025
Q4
$771K Sell
2,200
-100
-4% -$33.8K ﹤0.01% 836
2025
Q3
$743K Buy
+2,300
New +$715K ﹤0.01% 819

Other funds holding ELV

Vontobel Holding's ELV Position: Q1 2026 in Review

Vontobel Holding increased its Elevance Health (ELV) stake by 38% in Q1 2026, buying an estimated $858K and bringing the position to 9,453 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #472.

Vontobel Holding first reported a position in ELV in Q4 2020 and has held it in 22 quarters since. The position peaked at $10.2M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Vontobel Holding held 9,453 shares of Elevance Health worth $2.77M as of Q1 2026.
  • Vontobel Holding bought 2,611 Elevance Health shares in Q1 2026, an estimated $858K.
  • Elevance Health made up 0.01% of Vontobel Holding's portfolio in Q1 2026, its #472 holding.
  • Vontobel Holding first reported a position in Elevance Health in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Elevance Health position peaked at $10.2M in Q4 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.